The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of three (3) new Associate members on 1 January 2023. The new members joining EUCOPE network are: APCO Worldwide, RareLab and SKC. During the announcement, EUCOPE’s Secretary General Alexander Natz said, “The new year means… read more
A new initiative to boost research and development into rare and paediatric diseases will launch today [Thursday 8 December] at the European Health Summit. The ‘Rare Disease Moonshot’ is a commitment and collaboration between seven organisations to break down the barriers to finding new treatments and cures… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of three (3) new members at its quarterly Members Meeting on October 19th 2022 following Board approval. The new members joining EUCOPE network are: Genesis Pharma, Mirati Therapeutics and Moderna. During the announcement, EUCOPE’s Secretary… read more
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have concerns on the current direction of the implementation of the EU HTA Regulation. We are firmly convinced that the input from patient organizations, healthcare professionals, industry and HTA experts and… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of six (6) new members at its quarterly Members Meeting on June 22nd following Board approval. The new members joining EUCOPE network are: Amylyx Pharmaceuticals, Arnold&Porter, Bavarian Nordic, Laboratoire Cevidra and Urovant Sciences. During the… read more
BRUSSELS & BOSTON – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European trade body representing small and mid-sized innovative health technology companies, and the Massachusetts Biotechnology Council (MassBio), the association representing the premier global life sciences and healthcare hub, with 1,500+ members, have signed… read more
Yesterday, 3 May 2022, the European Commission published the proposal for a regulation introducing the European Health Data Space (EHDS). First introduced on the 16th of September by the European Commission President Ursula von der Leyen, the Commission aims for the EHDS to form a… read more
EUCOPE’s latest position paper outlines our vision for the evolution of the EU Regulatory framework and a modernisation of the Centralised Procedure to ultimately bring novel medicines earlier to patients. The European Centralised Procedure (CP) has helped and accelerated the approval of novel medicines across… read more
As the EU trade body for small to mid-sized companies that support, invest and produce the innovative medicines and therapies of the future, EUCOPE is happy to welcome five new members to its organisation. AOP Health, Enterome, Flatiron Health, Novo Nordisk and TETEC all became… read more
The European Commission is consulting stakeholders as part of its revision process of two major pieces of legislation, on medicines for rare diseases and paediatric patients. Central to the development of innovative treatments for these specific categories of patients, this revision process represents an important… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View